Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?

PURPOSE: The American College of Surgeons Oncology Group trial Z0011 demonstrated that axillary node dissection (ALND) can be omitted in patients managed with breast conserving surgery and 1 to 2 positive sentinel lymph nodes (SLNs) without adverse effects on locoregional recurrence or disease-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebhardt, Brian J., Thomas, Joel, Horne, Zachary D., Champ, Colin E., Farrugia, Daniel J., Diego, Emilia, Ahrendt, Gretchen M., Beriwal, Sushil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127974/
https://www.ncbi.nlm.nih.gov/pubmed/30197938
http://dx.doi.org/10.1016/j.adro.2018.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127974/
https://www.ncbi.nlm.nih.gov/pubmed/30197938
http://dx.doi.org/10.1016/j.adro.2018.03.004

Ejemplares similares